0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Next Generation Sequencing (NGS) Solution - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-22L13070
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Next Generation Sequencing NGS Solution Market Research Report 2023
BUY CHAPTERS

Next Generation Sequencing (NGS) Solution - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-22L13070
Report
October 2024
Pages:124
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Next Generation Sequencing (NGS) Solution - Market Size

The global market for Next Generation Sequencing (NGS) Solution was estimated to be worth US$ 3690 million in 2023 and is forecast to a readjusted size of US$ 10060 million by 2030 with a CAGR of 15.4% during the forecast period 2024-2030

Next Generation Sequencing (NGS) Solution - Market

Next Generation Sequencing (NGS) Solution - Market

Next Generation Sequencing (NGS), also known as high-throughput sequencing, refers to advanced genomic technologies that enable the rapid and cost-effective sequencing of DNA or RNA molecules. NGS solutions have revolutionized the field of genomics and have significant applications in various areas of life sciences, including medical research, diagnostics, personalized medicine, agriculture, and environmental studies.
The global market for Next Generation Sequencing (NGS) solutions has experienced significant growth in recent years, driven by the increasing adoption of NGS technologies in various research and clinical applications. NGS has revolutionized genomics research, personalized medicine, and diagnostics, making it one of the most impactful technologies in the life sciences industry. Continuous innovations in NGS platforms, sequencing chemistries, and bioinformatics tools have improved sequencing accuracy, speed, and data analysis capabilities. The increasing focus on understanding the genetic basis of diseases, population genomics, and agricultural genomics has driven the demand for NGS solutions. The United States and Canada are major contributors to the global NGS market due to their well-established research infrastructure and a large number of NGS-based research projects. European countries, including the United Kingdom, Germany, and France, have seen significant NGS adoption in both research and clinical applications. Countries like China, Japan, and India have witnessed rapid growth in the NGS market, driven by increasing research investments and government initiatives. The global market for NGS solutions is expected to continue its growth trajectory in the coming years. The increasing adoption of NGS in clinical diagnostics, precision medicine, and agriculture is likely to drive further market expansion. Moreover, ongoing advancements in NGS technologies, such as single-cell sequencing and long-read sequencing, will continue to unlock new research possibilities and applications, expanding the reach of NGS into various scientific disciplines.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Next Generation Sequencing (NGS) Solution, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Next Generation Sequencing (NGS) Solution by region & country, by Type, and by Application.
The Next Generation Sequencing (NGS) Solution market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Next Generation Sequencing (NGS) Solution.
Market Segmentation

Scope of Next Generation Sequencing (NGS) Solution - Market Report

Report Metric Details
Report Name Next Generation Sequencing (NGS) Solution - Market
Forecasted market size in 2030 US$ 10060 million
CAGR 15.4%
Forecasted years 2024 - 2030
Segment by Type:
  • Whole Genome Sequencing
  • Whole Exome Sequencing
  • Targeted Sequencing and Resequencing Centrifuges
Segment by Application
  • Sporadic Cancer
  • Inherited Cancer
  • Companion Diagnostics
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Eurofins Scientific, Illumina, PerkinElmer, Thermo Fisher Scientific, Roche Holding, Agilent Technologies, Myriad Genetics, Foundation Medicine, Oxford Nanopore Technologies, Pacific Biosciences, Paradigm Diagnostics, BGI Group, Caris Life Sciences, Partek, Natera, LabCorp, Macrogen, Genotypic Technology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Next Generation Sequencing (NGS) Solution manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Next Generation Sequencing (NGS) Solution in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Next Generation Sequencing (NGS) Solution in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Next Generation Sequencing (NGS) Solution - Market size in 2030?

Ans: The Next Generation Sequencing (NGS) Solution - Market size in 2030 will be US$ 10060 million.

Who are the main players in the Next Generation Sequencing (NGS) Solution - Market report?

Ans: The main players in the Next Generation Sequencing (NGS) Solution - Market are Eurofins Scientific, Illumina, PerkinElmer, Thermo Fisher Scientific, Roche Holding, Agilent Technologies, Myriad Genetics, Foundation Medicine, Oxford Nanopore Technologies, Pacific Biosciences, Paradigm Diagnostics, BGI Group, Caris Life Sciences, Partek, Natera, LabCorp, Macrogen, Genotypic Technology

What are the Application segmentation covered in the Next Generation Sequencing (NGS) Solution - Market report?

Ans: The Applications covered in the Next Generation Sequencing (NGS) Solution - Market report are Sporadic Cancer, Inherited Cancer, Companion Diagnostics, Others

What are the Type segmentation covered in the Next Generation Sequencing (NGS) Solution - Market report?

Ans: The Types covered in the Next Generation Sequencing (NGS) Solution - Market report are Whole Genome Sequencing, Whole Exome Sequencing, Targeted Sequencing and Resequencing Centrifuges

1 Market Overview
1.1 Next Generation Sequencing (NGS) Solution Product Introduction
1.2 Global Next Generation Sequencing (NGS) Solution Market Size Forecast
1.3 Next Generation Sequencing (NGS) Solution Market Trends & Drivers
1.3.1 Next Generation Sequencing (NGS) Solution Industry Trends
1.3.2 Next Generation Sequencing (NGS) Solution Market Drivers & Opportunity
1.3.3 Next Generation Sequencing (NGS) Solution Market Challenges
1.3.4 Next Generation Sequencing (NGS) Solution Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Next Generation Sequencing (NGS) Solution Players Revenue Ranking (2023)
2.2 Global Next Generation Sequencing (NGS) Solution Revenue by Company (2019-2024)
2.3 Key Companies Next Generation Sequencing (NGS) Solution Manufacturing Base Distribution and Headquarters
2.4 Key Companies Next Generation Sequencing (NGS) Solution Product Offered
2.5 Key Companies Time to Begin Mass Production of Next Generation Sequencing (NGS) Solution
2.6 Next Generation Sequencing (NGS) Solution Market Competitive Analysis
2.6.1 Next Generation Sequencing (NGS) Solution Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Next Generation Sequencing (NGS) Solution Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next Generation Sequencing (NGS) Solution as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Whole Genome Sequencing
3.1.2 Whole Exome Sequencing
3.1.3 Targeted Sequencing and Resequencing Centrifuges
3.2 Global Next Generation Sequencing (NGS) Solution Sales Value by Type
3.2.1 Global Next Generation Sequencing (NGS) Solution Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Next Generation Sequencing (NGS) Solution Sales Value, by Type (2019-2030)
3.2.3 Global Next Generation Sequencing (NGS) Solution Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Sporadic Cancer
4.1.2 Inherited Cancer
4.1.3 Companion Diagnostics
4.1.4 Others
4.2 Global Next Generation Sequencing (NGS) Solution Sales Value by Application
4.2.1 Global Next Generation Sequencing (NGS) Solution Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Next Generation Sequencing (NGS) Solution Sales Value, by Application (2019-2030)
4.2.3 Global Next Generation Sequencing (NGS) Solution Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Next Generation Sequencing (NGS) Solution Sales Value by Region
5.1.1 Global Next Generation Sequencing (NGS) Solution Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Next Generation Sequencing (NGS) Solution Sales Value by Region (2019-2024)
5.1.3 Global Next Generation Sequencing (NGS) Solution Sales Value by Region (2025-2030)
5.1.4 Global Next Generation Sequencing (NGS) Solution Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Next Generation Sequencing (NGS) Solution Sales Value, 2019-2030
5.2.2 North America Next Generation Sequencing (NGS) Solution Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Next Generation Sequencing (NGS) Solution Sales Value, 2019-2030
5.3.2 Europe Next Generation Sequencing (NGS) Solution Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Next Generation Sequencing (NGS) Solution Sales Value, 2019-2030
5.4.2 Asia Pacific Next Generation Sequencing (NGS) Solution Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Next Generation Sequencing (NGS) Solution Sales Value, 2019-2030
5.5.2 South America Next Generation Sequencing (NGS) Solution Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Next Generation Sequencing (NGS) Solution Sales Value, 2019-2030
5.6.2 Middle East & Africa Next Generation Sequencing (NGS) Solution Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Next Generation Sequencing (NGS) Solution Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Next Generation Sequencing (NGS) Solution Sales Value
6.3 United States
6.3.1 United States Next Generation Sequencing (NGS) Solution Sales Value, 2019-2030
6.3.2 United States Next Generation Sequencing (NGS) Solution Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Next Generation Sequencing (NGS) Solution Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Next Generation Sequencing (NGS) Solution Sales Value, 2019-2030
6.4.2 Europe Next Generation Sequencing (NGS) Solution Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Next Generation Sequencing (NGS) Solution Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Next Generation Sequencing (NGS) Solution Sales Value, 2019-2030
6.5.2 China Next Generation Sequencing (NGS) Solution Sales Value by Type (%), 2023 VS 2030
6.5.3 China Next Generation Sequencing (NGS) Solution Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Next Generation Sequencing (NGS) Solution Sales Value, 2019-2030
6.6.2 Japan Next Generation Sequencing (NGS) Solution Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Next Generation Sequencing (NGS) Solution Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Next Generation Sequencing (NGS) Solution Sales Value, 2019-2030
6.7.2 South Korea Next Generation Sequencing (NGS) Solution Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Next Generation Sequencing (NGS) Solution Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Next Generation Sequencing (NGS) Solution Sales Value, 2019-2030
6.8.2 Southeast Asia Next Generation Sequencing (NGS) Solution Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Next Generation Sequencing (NGS) Solution Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Next Generation Sequencing (NGS) Solution Sales Value, 2019-2030
6.9.2 India Next Generation Sequencing (NGS) Solution Sales Value by Type (%), 2023 VS 2030
6.9.3 India Next Generation Sequencing (NGS) Solution Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Eurofins Scientific
7.1.1 Eurofins Scientific Profile
7.1.2 Eurofins Scientific Main Business
7.1.3 Eurofins Scientific Next Generation Sequencing (NGS) Solution Products, Services and Solutions
7.1.4 Eurofins Scientific Next Generation Sequencing (NGS) Solution Revenue (US$ Million) & (2019-2024)
7.1.5 Eurofins Scientific Recent Developments
7.2 Illumina
7.2.1 Illumina Profile
7.2.2 Illumina Main Business
7.2.3 Illumina Next Generation Sequencing (NGS) Solution Products, Services and Solutions
7.2.4 Illumina Next Generation Sequencing (NGS) Solution Revenue (US$ Million) & (2019-2024)
7.2.5 Illumina Recent Developments
7.3 PerkinElmer
7.3.1 PerkinElmer Profile
7.3.2 PerkinElmer Main Business
7.3.3 PerkinElmer Next Generation Sequencing (NGS) Solution Products, Services and Solutions
7.3.4 PerkinElmer Next Generation Sequencing (NGS) Solution Revenue (US$ Million) & (2019-2024)
7.3.5 Thermo Fisher Scientific Recent Developments
7.4 Thermo Fisher Scientific
7.4.1 Thermo Fisher Scientific Profile
7.4.2 Thermo Fisher Scientific Main Business
7.4.3 Thermo Fisher Scientific Next Generation Sequencing (NGS) Solution Products, Services and Solutions
7.4.4 Thermo Fisher Scientific Next Generation Sequencing (NGS) Solution Revenue (US$ Million) & (2019-2024)
7.4.5 Thermo Fisher Scientific Recent Developments
7.5 Roche Holding
7.5.1 Roche Holding Profile
7.5.2 Roche Holding Main Business
7.5.3 Roche Holding Next Generation Sequencing (NGS) Solution Products, Services and Solutions
7.5.4 Roche Holding Next Generation Sequencing (NGS) Solution Revenue (US$ Million) & (2019-2024)
7.5.5 Roche Holding Recent Developments
7.6 Agilent Technologies
7.6.1 Agilent Technologies Profile
7.6.2 Agilent Technologies Main Business
7.6.3 Agilent Technologies Next Generation Sequencing (NGS) Solution Products, Services and Solutions
7.6.4 Agilent Technologies Next Generation Sequencing (NGS) Solution Revenue (US$ Million) & (2019-2024)
7.6.5 Agilent Technologies Recent Developments
7.7 Myriad Genetics
7.7.1 Myriad Genetics Profile
7.7.2 Myriad Genetics Main Business
7.7.3 Myriad Genetics Next Generation Sequencing (NGS) Solution Products, Services and Solutions
7.7.4 Myriad Genetics Next Generation Sequencing (NGS) Solution Revenue (US$ Million) & (2019-2024)
7.7.5 Myriad Genetics Recent Developments
7.8 Foundation Medicine
7.8.1 Foundation Medicine Profile
7.8.2 Foundation Medicine Main Business
7.8.3 Foundation Medicine Next Generation Sequencing (NGS) Solution Products, Services and Solutions
7.8.4 Foundation Medicine Next Generation Sequencing (NGS) Solution Revenue (US$ Million) & (2019-2024)
7.8.5 Foundation Medicine Recent Developments
7.9 Oxford Nanopore Technologies
7.9.1 Oxford Nanopore Technologies Profile
7.9.2 Oxford Nanopore Technologies Main Business
7.9.3 Oxford Nanopore Technologies Next Generation Sequencing (NGS) Solution Products, Services and Solutions
7.9.4 Oxford Nanopore Technologies Next Generation Sequencing (NGS) Solution Revenue (US$ Million) & (2019-2024)
7.9.5 Oxford Nanopore Technologies Recent Developments
7.10 Pacific Biosciences
7.10.1 Pacific Biosciences Profile
7.10.2 Pacific Biosciences Main Business
7.10.3 Pacific Biosciences Next Generation Sequencing (NGS) Solution Products, Services and Solutions
7.10.4 Pacific Biosciences Next Generation Sequencing (NGS) Solution Revenue (US$ Million) & (2019-2024)
7.10.5 Pacific Biosciences Recent Developments
7.11 Paradigm Diagnostics
7.11.1 Paradigm Diagnostics Profile
7.11.2 Paradigm Diagnostics Main Business
7.11.3 Paradigm Diagnostics Next Generation Sequencing (NGS) Solution Products, Services and Solutions
7.11.4 Paradigm Diagnostics Next Generation Sequencing (NGS) Solution Revenue (US$ Million) & (2019-2024)
7.11.5 Paradigm Diagnostics Recent Developments
7.12 BGI Group
7.12.1 BGI Group Profile
7.12.2 BGI Group Main Business
7.12.3 BGI Group Next Generation Sequencing (NGS) Solution Products, Services and Solutions
7.12.4 BGI Group Next Generation Sequencing (NGS) Solution Revenue (US$ Million) & (2019-2024)
7.12.5 BGI Group Recent Developments
7.13 Caris Life Sciences
7.13.1 Caris Life Sciences Profile
7.13.2 Caris Life Sciences Main Business
7.13.3 Caris Life Sciences Next Generation Sequencing (NGS) Solution Products, Services and Solutions
7.13.4 Caris Life Sciences Next Generation Sequencing (NGS) Solution Revenue (US$ Million) & (2019-2024)
7.13.5 Caris Life Sciences Recent Developments
7.14 Partek
7.14.1 Partek Profile
7.14.2 Partek Main Business
7.14.3 Partek Next Generation Sequencing (NGS) Solution Products, Services and Solutions
7.14.4 Partek Next Generation Sequencing (NGS) Solution Revenue (US$ Million) & (2019-2024)
7.14.5 Partek Recent Developments
7.15 Natera
7.15.1 Natera Profile
7.15.2 Natera Main Business
7.15.3 Natera Next Generation Sequencing (NGS) Solution Products, Services and Solutions
7.15.4 Natera Next Generation Sequencing (NGS) Solution Revenue (US$ Million) & (2019-2024)
7.15.5 Natera Recent Developments
7.16 LabCorp
7.16.1 LabCorp Profile
7.16.2 LabCorp Main Business
7.16.3 LabCorp Next Generation Sequencing (NGS) Solution Products, Services and Solutions
7.16.4 LabCorp Next Generation Sequencing (NGS) Solution Revenue (US$ Million) & (2019-2024)
7.16.5 LabCorp Recent Developments
7.17 Macrogen
7.17.1 Macrogen Profile
7.17.2 Macrogen Main Business
7.17.3 Macrogen Next Generation Sequencing (NGS) Solution Products, Services and Solutions
7.17.4 Macrogen Next Generation Sequencing (NGS) Solution Revenue (US$ Million) & (2019-2024)
7.17.5 Macrogen Recent Developments
7.18 Genotypic Technology
7.18.1 Genotypic Technology Profile
7.18.2 Genotypic Technology Main Business
7.18.3 Genotypic Technology Next Generation Sequencing (NGS) Solution Products, Services and Solutions
7.18.4 Genotypic Technology Next Generation Sequencing (NGS) Solution Revenue (US$ Million) & (2019-2024)
7.18.5 Genotypic Technology Recent Developments
8 Industry Chain Analysis
8.1 Next Generation Sequencing (NGS) Solution Industrial Chain
8.2 Next Generation Sequencing (NGS) Solution Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Next Generation Sequencing (NGS) Solution Sales Model
8.5.2 Sales Channel
8.5.3 Next Generation Sequencing (NGS) Solution Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Next Generation Sequencing (NGS) Solution Market Trends
    Table 2. Next Generation Sequencing (NGS) Solution Market Drivers & Opportunity
    Table 3. Next Generation Sequencing (NGS) Solution Market Challenges
    Table 4. Next Generation Sequencing (NGS) Solution Market Restraints
    Table 5. Global Next Generation Sequencing (NGS) Solution Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Next Generation Sequencing (NGS) Solution Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Next Generation Sequencing (NGS) Solution Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Next Generation Sequencing (NGS) Solution Product Type
    Table 9. Key Companies Time to Begin Mass Production of Next Generation Sequencing (NGS) Solution
    Table 10. Global Next Generation Sequencing (NGS) Solution Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next Generation Sequencing (NGS) Solution as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Next Generation Sequencing (NGS) Solution Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Next Generation Sequencing (NGS) Solution Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Next Generation Sequencing (NGS) Solution Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Next Generation Sequencing (NGS) Solution Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Next Generation Sequencing (NGS) Solution Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Next Generation Sequencing (NGS) Solution Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Next Generation Sequencing (NGS) Solution Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Next Generation Sequencing (NGS) Solution Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Next Generation Sequencing (NGS) Solution Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Next Generation Sequencing (NGS) Solution Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Next Generation Sequencing (NGS) Solution Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Next Generation Sequencing (NGS) Solution Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Next Generation Sequencing (NGS) Solution Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Next Generation Sequencing (NGS) Solution Sales Value by Region (2019-2024) & (%)
    Table 27. Global Next Generation Sequencing (NGS) Solution Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Next Generation Sequencing (NGS) Solution Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Next Generation Sequencing (NGS) Solution Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Next Generation Sequencing (NGS) Solution Sales Value, (2025-2030) & (US$ Million)
    Table 31. Eurofins Scientific Basic Information List
    Table 32. Eurofins Scientific Description and Business Overview
    Table 33. Eurofins Scientific Next Generation Sequencing (NGS) Solution Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Next Generation Sequencing (NGS) Solution Business of Eurofins Scientific (2019-2024)
    Table 35. Eurofins Scientific Recent Developments
    Table 36. Illumina Basic Information List
    Table 37. Illumina Description and Business Overview
    Table 38. Illumina Next Generation Sequencing (NGS) Solution Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Next Generation Sequencing (NGS) Solution Business of Illumina (2019-2024)
    Table 40. Illumina Recent Developments
    Table 41. PerkinElmer Basic Information List
    Table 42. PerkinElmer Description and Business Overview
    Table 43. PerkinElmer Next Generation Sequencing (NGS) Solution Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Next Generation Sequencing (NGS) Solution Business of PerkinElmer (2019-2024)
    Table 45. PerkinElmer Recent Developments
    Table 46. Thermo Fisher Scientific Basic Information List
    Table 47. Thermo Fisher Scientific Description and Business Overview
    Table 48. Thermo Fisher Scientific Next Generation Sequencing (NGS) Solution Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Next Generation Sequencing (NGS) Solution Business of Thermo Fisher Scientific (2019-2024)
    Table 50. Thermo Fisher Scientific Recent Developments
    Table 51. Roche Holding Basic Information List
    Table 52. Roche Holding Description and Business Overview
    Table 53. Roche Holding Next Generation Sequencing (NGS) Solution Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Next Generation Sequencing (NGS) Solution Business of Roche Holding (2019-2024)
    Table 55. Roche Holding Recent Developments
    Table 56. Agilent Technologies Basic Information List
    Table 57. Agilent Technologies Description and Business Overview
    Table 58. Agilent Technologies Next Generation Sequencing (NGS) Solution Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Next Generation Sequencing (NGS) Solution Business of Agilent Technologies (2019-2024)
    Table 60. Agilent Technologies Recent Developments
    Table 61. Myriad Genetics Basic Information List
    Table 62. Myriad Genetics Description and Business Overview
    Table 63. Myriad Genetics Next Generation Sequencing (NGS) Solution Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Next Generation Sequencing (NGS) Solution Business of Myriad Genetics (2019-2024)
    Table 65. Myriad Genetics Recent Developments
    Table 66. Foundation Medicine Basic Information List
    Table 67. Foundation Medicine Description and Business Overview
    Table 68. Foundation Medicine Next Generation Sequencing (NGS) Solution Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Next Generation Sequencing (NGS) Solution Business of Foundation Medicine (2019-2024)
    Table 70. Foundation Medicine Recent Developments
    Table 71. Oxford Nanopore Technologies Basic Information List
    Table 72. Oxford Nanopore Technologies Description and Business Overview
    Table 73. Oxford Nanopore Technologies Next Generation Sequencing (NGS) Solution Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Next Generation Sequencing (NGS) Solution Business of Oxford Nanopore Technologies (2019-2024)
    Table 75. Oxford Nanopore Technologies Recent Developments
    Table 76. Pacific Biosciences Basic Information List
    Table 77. Pacific Biosciences Description and Business Overview
    Table 78. Pacific Biosciences Next Generation Sequencing (NGS) Solution Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Next Generation Sequencing (NGS) Solution Business of Pacific Biosciences (2019-2024)
    Table 80. Pacific Biosciences Recent Developments
    Table 81. Paradigm Diagnostics Basic Information List
    Table 82. Paradigm Diagnostics Description and Business Overview
    Table 83. Paradigm Diagnostics Next Generation Sequencing (NGS) Solution Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Next Generation Sequencing (NGS) Solution Business of Paradigm Diagnostics (2019-2024)
    Table 85. Paradigm Diagnostics Recent Developments
    Table 86. BGI Group Basic Information List
    Table 87. BGI Group Description and Business Overview
    Table 88. BGI Group Next Generation Sequencing (NGS) Solution Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Next Generation Sequencing (NGS) Solution Business of BGI Group (2019-2024)
    Table 90. BGI Group Recent Developments
    Table 91. Caris Life Sciences Basic Information List
    Table 92. Caris Life Sciences Description and Business Overview
    Table 93. Caris Life Sciences Next Generation Sequencing (NGS) Solution Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Next Generation Sequencing (NGS) Solution Business of Caris Life Sciences (2019-2024)
    Table 95. Caris Life Sciences Recent Developments
    Table 96. Partek Basic Information List
    Table 97. Partek Description and Business Overview
    Table 98. Partek Next Generation Sequencing (NGS) Solution Products, Services and Solutions
    Table 99. Revenue (US$ Million) in Next Generation Sequencing (NGS) Solution Business of Partek (2019-2024)
    Table 100. Partek Recent Developments
    Table 101. Natera Basic Information List
    Table 102. Natera Description and Business Overview
    Table 103. Natera Next Generation Sequencing (NGS) Solution Products, Services and Solutions
    Table 104. Revenue (US$ Million) in Next Generation Sequencing (NGS) Solution Business of Natera (2019-2024)
    Table 105. Natera Recent Developments
    Table 106. LabCorp Basic Information List
    Table 107. LabCorp Description and Business Overview
    Table 108. LabCorp Next Generation Sequencing (NGS) Solution Products, Services and Solutions
    Table 109. Revenue (US$ Million) in Next Generation Sequencing (NGS) Solution Business of LabCorp (2019-2024)
    Table 110. LabCorp Recent Developments
    Table 111. Macrogen Basic Information List
    Table 112. Macrogen Description and Business Overview
    Table 113. Macrogen Next Generation Sequencing (NGS) Solution Products, Services and Solutions
    Table 114. Revenue (US$ Million) in Next Generation Sequencing (NGS) Solution Business of Macrogen (2019-2024)
    Table 115. Macrogen Recent Developments
    Table 116. Genotypic Technology Basic Information List
    Table 117. Genotypic Technology Description and Business Overview
    Table 118. Genotypic Technology Next Generation Sequencing (NGS) Solution Products, Services and Solutions
    Table 119. Revenue (US$ Million) in Next Generation Sequencing (NGS) Solution Business of Genotypic Technology (2019-2024)
    Table 120. Genotypic Technology Recent Developments
    Table 121. Key Raw Materials Lists
    Table 122. Raw Materials Key Suppliers Lists
    Table 123. Next Generation Sequencing (NGS) Solution Downstream Customers
    Table 124. Next Generation Sequencing (NGS) Solution Distributors List
    Table 125. Research Programs/Design for This Report
    Table 126. Key Data Information from Secondary Sources
    Table 127. Key Data Information from Primary Sources
    Table 128. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Next Generation Sequencing (NGS) Solution Product Picture
    Figure 2. Global Next Generation Sequencing (NGS) Solution Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Next Generation Sequencing (NGS) Solution Sales Value (2019-2030) & (US$ Million)
    Figure 4. Next Generation Sequencing (NGS) Solution Report Years Considered
    Figure 5. Global Next Generation Sequencing (NGS) Solution Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Next Generation Sequencing (NGS) Solution Revenue in 2023
    Figure 7. Next Generation Sequencing (NGS) Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Whole Genome Sequencing Picture
    Figure 9. Whole Exome Sequencing Picture
    Figure 10. Targeted Sequencing and Resequencing Centrifuges Picture
    Figure 11. Global Next Generation Sequencing (NGS) Solution Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 12. Global Next Generation Sequencing (NGS) Solution Sales Value Market Share by Type, 2023 & 2030
    Figure 13. Product Picture of Sporadic Cancer
    Figure 14. Product Picture of Inherited Cancer
    Figure 15. Product Picture of Companion Diagnostics
    Figure 16. Product Picture of Others
    Figure 17. Global Next Generation Sequencing (NGS) Solution Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 18. Global Next Generation Sequencing (NGS) Solution Sales Value Market Share by Application, 2023 & 2030
    Figure 19. North America Next Generation Sequencing (NGS) Solution Sales Value (2019-2030) & (US$ Million)
    Figure 20. North America Next Generation Sequencing (NGS) Solution Sales Value by Country (%), 2023 VS 2030
    Figure 21. Europe Next Generation Sequencing (NGS) Solution Sales Value (2019-2030) & (US$ Million)
    Figure 22. Europe Next Generation Sequencing (NGS) Solution Sales Value by Country (%), 2023 VS 2030
    Figure 23. Asia Pacific Next Generation Sequencing (NGS) Solution Sales Value (2019-2030) & (US$ Million)
    Figure 24. Asia Pacific Next Generation Sequencing (NGS) Solution Sales Value by Country (%), 2023 VS 2030
    Figure 25. South America Next Generation Sequencing (NGS) Solution Sales Value (2019-2030) & (US$ Million)
    Figure 26. South America Next Generation Sequencing (NGS) Solution Sales Value by Country (%), 2023 VS 2030
    Figure 27. Middle East & Africa Next Generation Sequencing (NGS) Solution Sales Value (2019-2030) & (US$ Million)
    Figure 28. Middle East & Africa Next Generation Sequencing (NGS) Solution Sales Value by Country (%), 2023 VS 2030
    Figure 29. Key Countries/Regions Next Generation Sequencing (NGS) Solution Sales Value (%), (2019-2030)
    Figure 30. United States Next Generation Sequencing (NGS) Solution Sales Value, (2019-2030) & (US$ Million)
    Figure 31. United States Next Generation Sequencing (NGS) Solution Sales Value by Type (%), 2023 VS 2030
    Figure 32. United States Next Generation Sequencing (NGS) Solution Sales Value by Application (%), 2023 VS 2030
    Figure 33. Europe Next Generation Sequencing (NGS) Solution Sales Value, (2019-2030) & (US$ Million)
    Figure 34. Europe Next Generation Sequencing (NGS) Solution Sales Value by Type (%), 2023 VS 2030
    Figure 35. Europe Next Generation Sequencing (NGS) Solution Sales Value by Application (%), 2023 VS 2030
    Figure 36. China Next Generation Sequencing (NGS) Solution Sales Value, (2019-2030) & (US$ Million)
    Figure 37. China Next Generation Sequencing (NGS) Solution Sales Value by Type (%), 2023 VS 2030
    Figure 38. China Next Generation Sequencing (NGS) Solution Sales Value by Application (%), 2023 VS 2030
    Figure 39. Japan Next Generation Sequencing (NGS) Solution Sales Value, (2019-2030) & (US$ Million)
    Figure 40. Japan Next Generation Sequencing (NGS) Solution Sales Value by Type (%), 2023 VS 2030
    Figure 41. Japan Next Generation Sequencing (NGS) Solution Sales Value by Application (%), 2023 VS 2030
    Figure 42. South Korea Next Generation Sequencing (NGS) Solution Sales Value, (2019-2030) & (US$ Million)
    Figure 43. South Korea Next Generation Sequencing (NGS) Solution Sales Value by Type (%), 2023 VS 2030
    Figure 44. South Korea Next Generation Sequencing (NGS) Solution Sales Value by Application (%), 2023 VS 2030
    Figure 45. Southeast Asia Next Generation Sequencing (NGS) Solution Sales Value, (2019-2030) & (US$ Million)
    Figure 46. Southeast Asia Next Generation Sequencing (NGS) Solution Sales Value by Type (%), 2023 VS 2030
    Figure 47. Southeast Asia Next Generation Sequencing (NGS) Solution Sales Value by Application (%), 2023 VS 2030
    Figure 48. India Next Generation Sequencing (NGS) Solution Sales Value, (2019-2030) & (US$ Million)
    Figure 49. India Next Generation Sequencing (NGS) Solution Sales Value by Type (%), 2023 VS 2030
    Figure 50. India Next Generation Sequencing (NGS) Solution Sales Value by Application (%), 2023 VS 2030
    Figure 51. Next Generation Sequencing (NGS) Solution Industrial Chain
    Figure 52. Next Generation Sequencing (NGS) Solution Manufacturing Cost Structure
    Figure 53. Channels of Distribution (Direct Sales, and Distribution)
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Substrate Cutting Device Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-23Z18292
Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Targeted Radionuclide Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-14Z15017
Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Global Microfluidic Single-Cell Analysis and Screening System Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-7M18883
Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Medicinal Liquid Filling Equipment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-37J14968
Thu Dec 12 00:00:00 UTC 2024

Add to Cart